EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Abuse of gabapentinoids in individuals with substance use disorders

İnci Sağlam iD, Rukiye Aslan iD, Serap Annette Akgür iD, Yusuf Kurtulmuş iD

Journal of Forensic Sciences · 2025

DOI: 10.1111/1556-4029.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Forensic Sciences, 2025. Verfasst von İnci Sağlam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Manisa Mental Health and Disorders Hospital, Manisa, Turkey. Hauptthemen laut MEDLINE: Substance-Related Disorders, Gabapentin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abuse of gabapentinoids has increased rapidly, and death cases have been reported with increasing rates. This study examines the toxicological analysis data of substance abuse cases conducted after legal regulations were implemented in Türkiye. The focus will be on the medicolegal implications of gabapentinoid positivity in these cases. Urine samples collected between July 2021 and July 2022 from individuals (ages 18–45) presenting at Manisa Mental Health and Diseases Hospital with diagnosed or suspected substance use disorders were analyzed for the presence of pregabalin, gabapentin, and other accompanying substances. High‐resolution liquid chromatography‐mass spectrometry (Orbitrap) was employed for analysis. The analysis reports and sociodemographic data of 10,300 cases were retrieved from the patient record system and subjected to statistical analysis using SPSS 25.0. Gabapentinoid positivity was detected in 21.6% ( n = 2224) of these cases (pregabalin (PGB) 18.9% ( n = 1943) and gabapentin (GBP) 5.3% ( n = 546)). Of the positive cases, 93.9% ( n = 2089) were male, with an average age of 28 ± 6.7. Forensic cases (probation and judicial) represented the majority of admitted and positive cases 2.6% ( n = 265) of cases tested positive for both pregabalin and gabapentin. While an overall increase in pregabalin and gabapentin positivity rates was observed over time, a statistically significant difference ( p < 0.05) was noted between years. Seven substances were detected with gabapentinoids. Methamphetamine was the most common accompanying substance, representing nearly half of the detected substances (46.8%, n = 1040), followed by THC‐COOH (26.8%, n = 595). Despite legal regulations, the use of gabapentinoids is increasing rapidly. The study highlights the urgent need to include gabapentinoids in routine screening tests, enforce stricter prescribing guidelines, and actively prevent their illegal use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersGabapentinHumansAdultMaleFemaleMiddle AgedYoung AdultAdolescentPregabalinChromatography, LiquidMass SpectrometrySubstance Abuse DetectionForensic Toxicology

Stichwörter der Autor:innen

abuse of gabapentinoidsgabapentinpregabalinprobationsubstance use disorderstoxicological analysis

Substanzen

GabapentinPregabalin

Autor:innen und Institutionen

  • Manisa Mental Health and Disorders Hospital, Manisa, Turkey.
  • Institute on Drug Abuse, Toxicology and Pharmaceutical Science, Ege University, Izmir, Turkey.

ORCID-Profile: İnci Sağlam, Rukiye Aslan, Serap Annette Akgür, Yusuf Kurtulmuş

Zitieren

APA

Sağlam, İ., Aslan, R., Akgür, S. A., & Kurtulmuş, Y. (2025). Abuse of gabapentinoids in individuals with substance use disorders. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.70028

Vancouver

Sağlam İ, Aslan R, Akgür SA, Kurtulmuş Y. Abuse of gabapentinoids in individuals with substance use disorders. Journal of Forensic Sciences. 2025. doi:10.1111/1556-4029.70028

BibTeX
@article{Salam2025,
  author = {Sağlam, İnci and Aslan, Rukiye and Akgür, Serap Annette and Kurtulmuş, Yusuf},
  title = {Abuse of gabapentinoids in individuals with substance use disorders},
  journal = {Journal of Forensic Sciences},
  year = {2025},
  doi = {10.1111/1556-4029.70028}
}
Kostenlos starten →